"Situato nel capoluogo del Cantone Ticino, l'Ospedale Regionale di Bellinzona e Valli è parte della rete sanitaria fra l'Ospedale Regionale di Bellinzona e gli ospedali di Faido e Acquarossa che è stata costituita nel 2000. L'Ospedale ha il compito di assicurare al distretto di Bellinzona e alle Valli l'assistenza ospedaliera di base e una serie di servizi specialistici di dimensione regionale e cantonale."

During the past decade, Ospedale San Giovanni conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 4 clinical trials were completed, i.e. on average, 10.5% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 3 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale San Giovanni" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 15 trials, followed by "Swiss Group for Clinical Cancer Research" with 9 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Ospedale Regionale Bellinzona e Valli" with 3 trials sponsored and "Ospedale San Giovanni Bellinzona" with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale San Giovanni" #1 collaborator was "Cancer Trials Ireland" with 2 trials as a collaborator, "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 2 trials as a collaborator and "Nordic CLL Study Group (NCLLSG)" with 2 trials as a collaborator. Other collaborators include 56 different institutions and companies that were collaborators in the rest 64 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale San Giovanni" are "Lung Cancer" (4 trials), "Ovarian Cancer" (4 trials), "Head and Neck Cancer" (3 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (3 trials) and "Brain and Central Nervous System Tumors" (2 trials). Many other conditions were trialed in "Ospedale San Giovanni" in a lesser frequency.

Most popular intervention types in "Ospedale San Giovanni" are "Drug" (44 trials), "Biological" (7 trials), "Other" (7 trials), "Radiation" (7 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (6 trials), "cisplatin" (4 trials), "Cytarabine" (3 trials), "Doxorubicin" (3 trials) and "Durvalumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale San Giovanni" are 61 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale San Giovanni". undefined are not yet recruiting, 14 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 35 completed trials in Ospedale San Giovanni, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale San Giovanni, 10 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".